Silybin Cocrystals with Improved Solubility and Bioavailability

Area of Science:

• Pharmacology
• Materials Science
• Drug Delivery

Background:

• Silymarin, derived from milk thistle, shows therapeutic promise for liver disorders.
• The clinical application of Silybin, its primary active component, is hindered by poor solubility and low bioavailability.
• Novel formulation strategies are needed to enhance Silybin's therapeutic potential.

Purpose of the Study:

• To develop and characterize a novel cocrystal of Silybin to improve its physicochemical properties.
• To evaluate the dissolution, supersaturation, and pharmacokinetic profile of the Silybin-L-proline cocrystal.
• To assess the potential of the cocrystal formulation for enhanced Silybin delivery.

Main Methods:

• Synthesis of Silybin-L-proline cocrystal.
• Physicochemical characterization using PXRD, TGA, DSC, and FTIR.
• In vitro dissolution studies in various pH conditions with precipitation inhibitors.
• In vivo pharmacokinetic evaluation in a rat model.

Main Results:

• The Silybin-L-proline cocrystal demonstrated significantly improved dissolution, especially in acidic media.
• Precipitation inhibitors, like PVP, effectively prolonged supersaturation.
• The cocrystal achieved a 16-fold increase in bioavailability in rats, surpassing a commercial formulation.

Conclusions:

• The Silybin-L-proline cocrystal represents a promising approach to enhance Silybin's dissolution and bioavailability.
• This formulation strategy holds potential for improving the clinical efficacy of silymarin in liver disease treatment.
• Further development could lead to more effective Silybin-based therapeutics.